Medicine

Partnering for Progress: Leveraging Advocacy Groups to Drive Awareness and Participation in IPF Trials

John Hood, CEO, Endeavor BioMedicines discusses partnering with advocacy groups to increase awareness of clinical trials for idiopathic pulmonary fibrosis.

Leave a Reply

Your email address will not be published. Required fields are marked *